Cite
Liposome-encapsulated hemoglobin (HbV) transfusion rescues rats undergoing progressive lethal 85% hemorrhage as a result of an anti-arrhythmogenic effect on the myocardium
MLA
Yuko Higashimura, et al. “Liposome-Encapsulated Hemoglobin (HbV) Transfusion Rescues Rats Undergoing Progressive Lethal 85% Hemorrhage as a Result of an Anti-Arrhythmogenic Effect on the Myocardium.” Artificial OrgansREFERENCES, vol. 45, no. 11, June 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2234827a08bdc78eb92dd30a7dbf03ea&authtype=sso&custid=ns315887.
APA
Yuko Higashimura, Hiromi Sakai, Haruka Asahina, Bonpei Takase, & Masayuki Ishihara. (2021). Liposome-encapsulated hemoglobin (HbV) transfusion rescues rats undergoing progressive lethal 85% hemorrhage as a result of an anti-arrhythmogenic effect on the myocardium. Artificial OrgansREFERENCES, 45(11).
Chicago
Yuko Higashimura, Hiromi Sakai, Haruka Asahina, Bonpei Takase, and Masayuki Ishihara. 2021. “Liposome-Encapsulated Hemoglobin (HbV) Transfusion Rescues Rats Undergoing Progressive Lethal 85% Hemorrhage as a Result of an Anti-Arrhythmogenic Effect on the Myocardium.” Artificial OrgansREFERENCES 45 (11). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2234827a08bdc78eb92dd30a7dbf03ea&authtype=sso&custid=ns315887.